FDA Inspection
University of Texas Southwestern Medical Center, TheUniversity of Texas Southwestern Medical Center, The – FDA Inspection, May 15, 2026
Record Details
This FDA Inspection record concerns University of Texas Southwestern Medical Center, The, with an inspection on May 15, 2026, issued by the Dallas District Office, covering human drugs.
- Inspection Date
- May 15, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 716268bd-9024-453a-8913-31ebe2e6480b
Inspection Facts
- Inspection number
- 1317258
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 212.71(a)Procedures to Investigate Cause of Non-Conforming Product
Full citation text and observation details available on the Dashboard.
Other FDA inspections of University of Texas Southwestern Medical Center, The
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2023 | Not classified | Dallas District Office | |
| September 13, 2019 | Not classified | Dallas District Office | |
| November 9, 2018 | Not classified | Dallas District Office | |
| August 2, 2017 | OAI | Dallas District Office | Generic Drug Evaluation |
| October 20, 2015 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for University of Texas Southwestern Medical Center, The
- FDA Inspection 1198460 - 2023-02-09
- FDA Inspection 1101987 - 2019-09-13
- FDA Inspection 1073752 - 2018-11-09
- FDA Inspection 1021093 - 2017-08-02
- FDA Inspection 946171 - 2015-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.